Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Autor: A. Goldhirsch, Richard D. Gelber, S. Aebi, Edda Simoncini, Diana Crivellari, Barry A. Gusterson, Danielle Braun, Per Karlsson, Zhuoxin Sun, Meredith M. Regan, Manuela Rabaglio, Karen N. Price, J. Lindtner, M. Castiglione-Gertsch, Alan S. Coates, Raymond Snyder, Giuseppe Viale

Publikováno v: Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754

Background: The benefit of adjuvant chemotherapy in postmenopausal patients with estrogen receptor (ER)-positive lymph node-negative breast cancer is being reassessed. Patients and methods: After stratification by ER status, 1669 postmenopausal patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf82f7af05b736383c5103e291b5c758
http://doc.rero.ch/record/304488/files/mdq754.pdf

Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)

Autor: Ph Morel, H. P. Do, W. Van den Bogaert, M. F. Fey, P. Hueber, H. Schefer, G. Goitein, S. Bressan, C. Verdan, W. Jeanneret Sozzi, L. Escudé, J. Heuberger, J. C. Horiot, O. Stadelmann, S. Balmer Majno, D. Schneiter, G. Lutters, A. Schott, Damien C. Weber, R. Mini, Peter Thum, Gábor J. Székely, G. Höpfl, B. Lippold, A. Coray, A. Azria, J. B. Davis, M. Betz, A. Hügli, Y. Zimmer, S. Berthou, Ch. Landmann, T. Boehringer, M. I. Saunders, S. Gourgou, L. Bortoluzzi, G. Ries, M. Allaoua, E. J. Born, A. Gallino, Christos Kolotas, G. Ueltschi, S. Bouville, Alessandra Bolsi, A. Richetti, K. T. Beer, S. Presilla, A. D. Roth, B. Streit, Richard H. Greiner, A. J. Lomax, F. Corminboeuf, J. Verwey, R. D. Gelber, J. Lindtner, O. Özsoy, R. Stupp, B. Thürlimann, R. H. Greiner, B. Hofstetter, I. F. Ciernik, M.-A. Bründler, C. von Briel, M. Honer, A. Merçay, E. Tschanz, M. Pruschy, L. Kemmerling, K. Rufibach, A. Franzetti, F. Luthi, A. Goldhirsch, J. Krayenbühl, St. Bodis, P. Martineau, Karl T. Beer, A. Pèlegrin, Peter D. Juelke, S. Cunat, J. Curschmann, M. Huser, A. Carbone, H. Rutz, Anthony Lomax, S. M. Bentzen, David Azria, W. Weder, N. Mach, H. Kranzbuehler, F. Mahler, L. Cozzi, P. Jichlinski, K. N. Price, M. Jörger, A. S. Coates, Christine Bouchardy, Frank Behrensmeier, Oscar Matzinger, Urs M. Lütolf, C. Taverna, H. Vees, D. Szczerba, R. Miralbell, D. Stalder, P. Pasche, C. Oehler, Eros Pedroni, M. Notter, P. Pujol, S. Bulling, W. Krek, D. Zingg, C. Larbouret, B. Pajic, G. Gruber, Oliver Riesterer, Beate Timmermann, L. Guillou, D. Weber, P. Dulguerov, P. Tebeu, F. Ludicke, P. Gervaz, Dagmar Laluhová, F. Munier, Abderrahim Zouhair, S. Lin, R. Gol-ouh, Ch. Taverna, M. Motta, R. Bigler, J. C. Luthi, S. Bieri, Malgorzata Roos, Paul Erne, S. Ganapathipillai, S. Ametamey, A. Tenzer, C. Burger, C. Bonny, B. J. Cummings, Stefanie Ohlerth, J. Bernier, M. Castiglione-Gertsch, M. Mollà, G. Pasche, J. F. Valley, G. Romieu, A. S. Allal, N. Stanek, U. Ulmer, Hans-Peter Hafner, S. Bodis, D. B. Evans, E. Pedroni, C.-M. Rudenstam, A. A. Khalil, G. Curti, D. M. Aebersold, C. Girardet, M. Jerman, A. Pica, G. Pache, E. Simoncini, R. Moeckli, T. Collen, A. Balmer, P. Mhawech, Peiman Jamshidi, Hans Peter Rutz, George N. Thalmann, Bernhard Isaak, E. E. Friedrich, M. Suleiman, M. Becker, D. Taussky, S. B. Holmberg, V. Vuong, Philippe Coucke, M. Abdou, Max Gassmann, G. Pesce, D. Crivellari, M. Weitzel, C. Rohrer Bley, H. Verkooijen, E. Schoenmaker, R. Stahel, R.O. Mirimanoff, C. Ares, M. Rouzaud, M. Bonetti, J. Collins, Barbara Kaser-Hotz, M. Bargetzi, P. Gertsch, H. P. Hafner, Y. Popowski, G. Nicolini, Natalie Inteeworn, Melanie Wergin, K. Allemann, P. Nouet, P. Kestenholz, H. Zenklusen, Brigitta G. Baumert, M. Usel, D. Lardinois, Therese Josephine Resink, S. Dische, H. Wang, H. Kranzbühler, T. Kebdani, D. Vetterli, H. J. Vees, W. Jochum, I. A. Norton, J. B. Dubois, C. Jargy, D. O. Slosman, A. Kramar, A. Fogliata, G. Studer, M. L. Nasi, Mahmut Ozsahin, G. Dipasquale, P. Huguenin

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 180

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3adcc2fa579d2d9f0fd5d3025a657d
https://pubmed.ncbi.nlm.nih.gov/27137923

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Autor: Nicole Rotmensz, Karen N. Price, Beat Thürlimann, John P. Collins, Diana Crivellari, C. Mendiola, O. Pagani, Edda Simoncini, Stefan Aebi, Aron Goldhirsch, Marco Colleoni, Richard D. Gelber, Alan S. Coates, Silvia Dellapasqua, M. Castiglione Gertsch, Aparna Keshaviah, J. Lindtner

Publikováno v: Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492

BACKGROUND: We evaluated the ability of CA15-3 and alkaline phosphatase (ALP) to predict breast cancer recurrence. PATIENTS AND METHODS: Data from seven International Breast Cancer Study Group trials were combined. The primary end point was relapse-f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c5d68c3cc0c56d8ed6caff6128c8ab
https://doi.org/10.1093/annonc/mdl492

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor

Autor: Stig Holmberg, C.-M. Rudenstam, S. Li, Karen N. Price, Diana Crivellari, Andrea Veronesi, A. Goldhirsch, D. Eržen, John F. Forbes, Beat Thürlimann, Edda Simoncini, John P. Collins, Marco Colleoni, Olivia Pagani, M. Castiglione-Gertsch, R. D. Gelber, J. Lindtner, Elizabeth Murray, Alan S. Coates

Publikováno v: Annals of Oncology. 16:716-725

Background Controversy persists about whether chemotherapy benefits all breast cancer patients. Patients and methods In the International Breast Cancer Study Group (IBCSG) trial VII, 1212 postmenopausal patients with node-positive disease were random

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf13251463ab62a46af8d4360061590
https://doi.org/10.1093/annonc/mdi163

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

Autor: A. Goldhirsch, Richard D. Gelber, Andrea Veronesi, John F. Forbes, Beat Thürlimann, Carl Magnus Rudenstam, David Zahrieh, John P. Collins, Alan S. Coates, Diana Crivellari, Elizabeth Murray, Juerg Bernhard, Raymond Snyder, K. N. Price, M. Castiglione-Gertsch, C. Hürny, Martin F. Fey, Lucien Perey

Publikováno v: British Journal of Cancer

We evaluated quality of life (QL) and quality-adjusted survival in International Breast Cancer Study Group Trial IX, a randomised trial including 1669 eligible patients receiving tamoxifen for 5 years or three prior cycles of cyclophosphamide, methot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b07efe85667aac33ed11f6c9dc082b6
https://doi.org/10.1038/sj.bjc.6602230